For patient's with Parkinson's disease, virtual house calls from neurologists may be of interest.
Telemedicine offers a convenient alternative for nonacute headache patients, researchers say.
E-health-based coagulation service was linked to lower frequency of adverse events, including thromboembolism, bleeding, and death.
There is little data to support telestroke for IV thrombolysis administration in the extended time window of 3 to 4.5 hours after stroke onset.
There are overwhelming concerns about reimbursement.
Patients in both groups were satisfied with their care.
Only 0.7% of rural beneficiaries received a telemedicine visit in 2013.
Communicating via e-mail reduced the number and phone calls and visits to the office.
The mobile unit allows for significantly shorter times to treatment with IV-tPA.
Providers should make sure that they hold the proper license and liability insurance to reduce risk.
A strong physician-patient relationship needs to be established in order to practice responsible telemedicine.
Fewer physicians are satisfied with their EHR system today than they were five years ago.
Despite elevated interest, many are unaware of current opportunities to connect and get information online.
Medicare beneficiaries have limited access to telemedicine services.
Another study suggests that a telehealth system could help objectively monitor dose adherence.
More than one-third of doctors recommended mobile health apps to their patients in past year.
Several apps are already in use collecting data on participants for studies on breast cancer, asthma, and Parkinson's disease.
A multidisciplinary team of providers come together to address epilepsy cases of patients with limited access to care.
The role of teleneurology can grow far beyond critical stroke care, but only if medical liabilities and insurance steps out of the way.
Developing telemedicine services is a near universal priority among health-care leaders.
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Early Clinical Traits of Multiple Sclerosis Prodrome Identified
- Chronic Pain May Be Contributor to Suicide
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- Ajovy Injection Approved for Migraine Prevention in Adults
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies
- Familial Hemiplegic Migraine Attacks May Be Associated With Cortical Swelling
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine
- Propofol May Decrease Delay in Neurocognitive Recovery